Antipsychotics-To Respond or Not to Respond?

A new study brings us closer to answering why antipsychotics are successful in treating schizophrenia in some patients and not in others.

Related Videos
Related Content

The Week in Review: March 20-24

March 25th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Schizophrenia and COVID 19: A Call for Collaborative Care

March 22nd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Prisoner of the Brain: Recognizing the Serious Implications of Catatonia

March 16th 2023

Research Analyzes Caffeine Intake and Levels in Smokers With Bipolar Disorder and Schizophrenia

March 13th 2023

The Week in Review: March 20-24

March 25th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Schizophrenia and COVID 19: A Call for Collaborative Care

March 22nd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Prisoner of the Brain: Recognizing the Serious Implications of Catatonia

March 16th 2023

Research Analyzes Caffeine Intake and Levels in Smokers With Bipolar Disorder and Schizophrenia

March 13th 2023

The Week in Review: March 20-24

March 25th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Schizophrenia and COVID 19: A Call for Collaborative Care

March 22nd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Prisoner of the Brain: Recognizing the Serious Implications of Catatonia

March 16th 2023

Research Analyzes Caffeine Intake and Levels in Smokers With Bipolar Disorder and Schizophrenia

March 13th 2023
© 2023 MJH Life Sciences

All rights reserved.